Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia. - Wikidata - awgldk - TriplyDB

Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia.

Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia.

http://www.wikidata.org/entity/Q36285608

about

The emerging role of ofatumumab in the treatment of chronic lymphocytic leukemia Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia.Routine treatment of patients with chronic lymphocytic leukaemia by office-based haematologists in Germany-data from the Prospective Tumour Registry Lymphatic Neoplasms.Leukemia-cell proliferation and disease progression in patients with early stage chronic lymphocytic leukemia.Clinical laboratory analysis of immunoglobulin heavy chain variable region genes for chronic lymphocytic leukemia prognosis.Analysis of CLLU1 expression levels before and after therapy in patients with chronic lymphocytic leukemia.Molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14.Waldenstrom macroglobulinemia Treatment with lenalidomide modulates T-cell immunophenotype and cytokine production in patients with chronic lymphocytic leukemia MicroRNA-223 is a novel negative regulator of HSP90B1 in CLL.The novel member of the BCL2 gene family, BCL2L12, is substantially elevated in chronic lymphocytic leukemia patients, supporting its value as a significant biomarker.Comprehensive characterization of immunoglobulin gene rearrangements in patients with chronic lymphocytic leukaemia.A phase 2 study of the BH3 mimetic BCL2 inhibitor navitoclax (ABT-263) with or without rituximab, in previously untreated B-cell chronic lymphocytic leukemia Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia The role of prognostic factors in assessing 'high-risk' subgroups of patients with chronic lymphocytic leukemia.A high number of losses in 13q14 chromosome band is associated with a worse outcome and biological differences in patients with B-cell chronic lymphoid leukemia.Adenosine Deaminase Activity in Chronic Lymphocytic Leukemia and Healthy Subjects.Ibrutinib for B cell malignancies.Next-generation sequencing and FISH studies reveal the appearance of gene mutations and chromosomal abnormalities in hematopoietic progenitors in chronic lymphocytic leukemia.Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approaches.Overview of available p53 function tests in relation to TP53 and ATM gene alterations and chemoresistance in chronic lymphocytic leukemia.Analysis of chronic lymphotic leukemia transcriptomic profile: differences between molecular subgroups.The genome of chemorefractory chronic lymphocytic leukemia reveals frequent mutations of NOTCH1 and SF3B1.TET2 overexpression in chronic lymphocytic leukemia is unrelated to the presence of TET2 variations.Structural alterations in chronic lymphocytic leukaemia. Cytogenetic and FISH analysis.Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia.A study for proposal of use of regulatory T cells as a prognostic marker and establishing an optimal threshold level for their expression in chronic lymphocytic leukemia.p53 protein expression in chronic lymphocytic leukemia.Flow cytometric identification of 76 patients with biclonal disease among 5523 patients with chronic lymphocytic leukaemia (B-CLL) and its genetic characterization.ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia

P2860

Q24617708-F21F674E-36F1-45D3-8EB5-62A16E742D90 Q27851685-5E894849-D1B0-4101-A749-246B839D70AF Q30801095-8F1823B7-6235-466E-8B8C-499B6AC294F2 Q33774513-9304D903-388E-495D-A405-8DCFEE540B18 Q33856248-DB256705-84F2-4BF9-901F-D35FA8E200AF Q33965688-E0B8DF64-30C9-4BD4-9C0B-7F25C31392DB Q34477348-AA46CE7D-DDC2-471C-867E-B1A23F4C55C1 Q35097328-2C5CBDEB-D00E-4AAF-A349-5FAE0F595B4F Q35146081-CBFA1EEE-C67D-4EF0-ADBD-6863AB2BEBEF Q35496723-BF7F240E-A172-4CDD-A1E7-9A04930E9EB5 Q35584788-1D7F639B-88C7-4A05-AB9F-72ADD24CA2AB Q35867812-3182AA5A-E36D-47A9-B302-07EBFB8876D9 Q36276017-3394E2F5-D850-41FE-93E3-385805DD0604 Q36843749-1AB1EC3C-30D3-41C2-9A79-7E680EDB0DA5 Q36849336-A607DC32-E214-41F5-998B-C3ACF7EDB43A Q37112857-0F22BE25-135F-4E81-BB5B-DBE469949517 Q37289305-2B24C75F-C9B5-4F31-813E-A31CA9DC272E Q37555418-85966713-E733-4823-A130-CC32E4FD234A Q37747984-B1BFF148-C9F8-4492-AEDB-655B85F280FE Q37910914-25D592B6-239A-4122-82CC-AE913E8DB23E Q38101382-7EE637FD-B858-41C1-A782-0EC61EF2469C Q38511275-499E3111-CD42-46A9-98A4-BCCB0C6FC8CE Q40817325-39708FE1-B312-4F8A-A8B1-0B225C6B9425 Q42416286-6B304410-AA21-4A75-8F01-13723D7817A6 Q43971337-A0AF887C-B691-41D4-8D15-8294554C80D7 Q44078664-61AB6942-3C2B-4263-953B-E45E25673242 Q54319044-A5C3C514-9B0D-4B5B-B278-4B585611F130 Q54330797-BE09BC50-E5B3-43BD-B01C-FA3518E34906 Q54595113-11C0889F-5D73-46A2-8210-70843E189273 Q58042037-8C3B2E12-4A6C-4D29-97B1-18184B1B741B

P2860

Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia.

http://www.wikidata.org/entity/Q36285608

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Perspectives on the use of new ...... chronic lymphocytic leukemia.

@ast

Perspectives on the use of new ...... chronic lymphocytic leukemia.

@en

Perspectives on the use of new ...... chronic lymphocytic leukemia.

@en-gb

type

label

Perspectives on the use of new ...... chronic lymphocytic leukemia.

@ast

Perspectives on the use of new ...... chronic lymphocytic leukemia.

@en

Perspectives on the use of new ...... chronic lymphocytic leukemia.

@en-gb

prefLabel

Perspectives on the use of new ...... chronic lymphocytic leukemia.

@ast

Perspectives on the use of new ...... chronic lymphocytic leukemia.

@en

Perspectives on the use of new ...... chronic lymphocytic leukemia.

@en-gb

P1433

Q36285608-59870419-C906-4B43-9B7A-DE065DE98683

P1476

Q36285608-49BFC5C6-AE60-4FEC-930A-C50E93ED552D

P2093

Q36285608-0BC378DF-9FE3-4055-A260-55E92B98A800

Q36285608-0C2B3D8B-53E3-4024-ACE1-C0A41D44AB18

Q36285608-11FC960F-F9B5-40ED-BDB3-B84BC0257628

Q36285608-1CD88167-1DD2-4672-BFFD-8919B82960C4

Q36285608-1EC09F46-7084-40C0-BD64-EFA4BF602A9B

Q36285608-815BC736-C918-46A9-BC17-2AFC2EC65146

Q36285608-863A81A3-D219-4C7F-84EC-6B5D3678BF49

Q36285608-949B0269-1A1B-4138-9B19-B203AEBE74F8

Q36285608-A5841A7F-054F-4B7C-BEFD-EBF16FEEB48C

P304

Q36285608-7BC81140-2F65-408C-86C4-7278A2BF0F0D

P31

Q36285608-2DF9A5AB-8956-49BB-B719-2CBC981462F5

P356

Q36285608-5B5EAB19-C4FF-4DB1-AC02-89F651B3B02A

P407

Q36285608-21AB877A-444C-408C-844D-A06821029E9C

P433

Q36285608-8F1B212C-1BEE-4017-AC72-02347AFA12DA

P478

Q36285608-2AAA677A-98B4-4640-ADBC-A2AADA1ED369

P50

Q36285608-41FAFA85-1A11-4C31-92A6-9FD7F5AF5DD0

Q36285608-75399740-5A2E-4D9C-BCAD-9ADAE7EBFBCF

Q36285608-B9A877B9-9539-4B55-8D60-C19A75038E66

Q36285608-D0672A32-1A12-4FC1-9FA9-938A2707A3C0

Q36285608-D7982F3A-D552-438D-B02E-22AE7E6F6209

P577

Q36285608-8133FB91-58FA-4997-9CFC-FB2F19E99979

P5875

Q36285608-8683C111-F88F-43F9-A458-01F1A458CDFE

P698

Q36285608-620FBD80-3F3E-4D02-8ED3-1DC69D77B080

P921

Q36285608-661FB185-BD30-44E1-9896-C2566B7B243A

Q36285608-BF1415A2-9090-4F15-84C8-ED6F24CB0432

P356

BLOOD-2005-04-1677

P1433

P1476

Perspectives on the use of new ...... chronic lymphocytic leukemia.

@en

P2093

Bruce Cheson

http://www.w3.org/2001/XMLSchema#string

Emili Montserrat

http://www.w3.org/2001/XMLSchema#string

Federico Caligaris-Cappio

http://www.w3.org/2001/XMLSchema#string

Guillaume Dighiero

http://www.w3.org/2001/XMLSchema#string

International Workshop on Chronic Lymphocytic Leukemia (IWCLL)

http://www.w3.org/2001/XMLSchema#string

Jacques-Louis Binet

http://www.w3.org/2001/XMLSchema#string

Kanti Rai

http://www.w3.org/2001/XMLSchema#string

Thomas J Kipps

http://www.w3.org/2001/XMLSchema#string

Tom Davis

http://www.w3.org/2001/XMLSchema#string

P304

859-861

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2005-04-1677

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P50

Daniel Catovsky

Hartmut Döhner

Michael J. Keating

P577

2005-10-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7542155

http://www.w3.org/2001/XMLSchema#string

P698

16223776

http://www.w3.org/2001/XMLSchema#string

P921